Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.8190
H.R.8190: Biosimilar Insulin Access Act of 2020
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Sept. 8, 2020
- Latest Major Action Sept. 16, 2020
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - Sept. 8, 2020
Bill Actions
Date | Description |
---|---|
Sept. 8, 2020 |
Referred to the House Committee on Energy and Commerce.
|
Sept. 8, 2020 |
Introduced in the House by Glenn Grothman (R-Wis.) |